Syngene International is currently trading at Rs. 643.70, up by 20.25 points or 3.25% from its pr...
The company reported standalone net profit of Rs 109.50 crore for the quarter ended December 31, ...
Lack of revenue catalysts Result Synopsis Syngene clocked a robust quarter with 25% YoY gr...
Syngene International is currently trading at Rs. 602.65, up by 1.55 points or 0.26% from its pre...
Syngene International is currently trading at Rs. 605.90, up by 4.80 points or 0.80% from its pre...
Syngene International is currently trading at Rs. 610.20, up by 23.15 points or 3.94% from its pr...
Syngene International is currently trading at Rs. 575.20, up by 4.30 points or 0.75% from its pre...
Bharat Electronics • On the weekly chart, the stock has decisively broken out its past ei...
An inline Q; lack of near term surprise keeps us away Our view Improvement in guidance from...
Lack of near term triggers Our view Management commentary remains positive around demand en...
Derivative Ideas SYNGENE FUTS added around 5% in open interest in as LONG buildup w...
Religare Super Idea To Read Complete Report & Disclaimer Click Here ...
Mixed numbers; Remdesivir impacts margins… About the stock: Syngene is an innovation-le...
Below is quote on Syngene international reported a weak set of numbers for Q1FY2022&nbs...
Our view After an outsized Remdesivir sales boost in Q1 and no change to 15% revenue growth gu...
Growth trajectory maintained, outlook upbeat… FY21 revenues grew 8.6% YoY to | 2184 cro...
BENGALURU - India's Syngene International Ltd aims to supply half-a-million vials of CO...
Result Highlights * FY22 guidance – Mid teens growth in revenues. EBIDTA margin expected...
Our View * Revenue acceleration from Mangalore API manufacturing may be back ended beyond FY2...
Below are Quote on Syngene Ltd By Mr. Yash Gupta Equity Research Associate, Angel Broki...
The company reported standalone net profit of Rs 101.80 crore for the quarter ended December 31, ...